Real-time enrollment status for this chickenpox clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 12:20 AM UTC
| NCT Number | NCT06693895 |
| Recruiting Status | Recruiting |
| Condition | Chickenpox |
| Phase | PHASE3 |
| Target Enrollment | 750 participants |
| Active Locations | 23 sites in the US |
| Sponsor | GlaxoSmithKline |
| Last Updated on CT.gov | May 29, 2026 (May 29, 2026) |
As of August 28, 2026: Clinical trial NCT06693895 is currently recruiting participants. This phase3 study for chickenpox is actively seeking new participants at 23 locations across the United States. The study is sponsored by GlaxoSmithKline. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06693895 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 23 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06693895 was last updated May 29, 2026 (May 29, 2026). HelloStudys verifies this status automatically.